Gupta, Prateek, Tegan Maharaj, Martin Weiss, Nasim Rahaman, Hannah Alsdurf, Abhinav Sharma, Nanor Minoyan, et al. ‘COVI-AgentSim: An Agent-Based Model for Evaluating Methods of Digital Contact Tracing’. ArXiv:2010.16004 [Cs], 29 October 2020. http://arxiv.org/abs/2010.16004.

COVID-19 Vaccines: Combating Misinformation. (n.d.). Pulitzer Center. Retrieved 25 February 2021, from https://pulitzercenter.org/event/covid-19-vaccines-combating-misinformation

Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G. (2016). Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20. Health Affairs, 35(2), 199–207. https://doi.org/10.1377/hlthaff.2015.1086

Jeffay, N. (n.d.). Israel sees 60% drop in hospitalizations for age 60-plus 3 weeks after 1st shot. Retrieved 16 February 2021, from https://www.timesofisrael.com/israel-sees-60-drop-in-hospitalizations-for-over-60s-in-weeks-after-vaccination/

Researchers propose that humidity from masks may lessen severity of COVID-19. (2021, February 12). National Institutes of Health (NIH). https://www.nih.gov/news-events/news-releases/researchers-propose-humidity-masks-may-lessen-severity-covid-19

Betsch, C., Böhm, R., & Korn, L. (2013). Inviting free-riders or appealing to prosocial behavior? Game-theoretical reflections on communicating herd immunity in vaccine advocacy. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 32(9), 978–985. https://doi.org/10.1037/a0031590

Grover, N. (2020, December 7). WHO looks at giving Covid-19 to healthy people to speed up vaccine trials. The Guardian. https://www.theguardian.com/world/2020/dec/07/who-looks-at-giving-covid-to-healthy-people-to-speed-up-vaccine-trials

Hu, C., Zhu, K., Huang, K., Yu, B., Jiang, W., Peng, K., & Wang, F. (2020, November 30). Using Natural Intervention to Promote Subjective Well-being of COVID-19 Essential Workers. https://doi.org/10.31234/osf.io/mc57s

Smith, A. M., Willroth, E. C., Gatchpazian, A., shallcross, amanda, Feinberg, M., & Ford, B. Q. (2020). Coping with Health Threats: The costs and benefits of managing emotions. [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/dn957

IZA – Institute of Labor Economics. ‘COVID-19 and the Labor Market’. Accessed 6 October 2020. https://covid-19.iza.org/publications/dp13644/.

Garrett, P. M., White, J. P., Lewandowsky, S., Kashima, Y., Perfors, A., Little, D. R., Geard, N., Mitchell, L., Tomko, M., & Dennis, S. (2020). The acceptability and uptake of smartphone tracking for COVID-19 in Australia [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/7tme6

Berman, J. Z., & Kupor, D. (2020). Moral Choice When Harming Is Unavoidable: Psychological Science. https://doi.org/10.1177/0956797620948821

Mercier, M., Vinchon, F., Pichot, N., Bonetto, E., Bonnardel, N., Girandola, F., & Lubart, T. (2020). COVID-19: A Boon or a Bane for Creativity? [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/c3vsr

Enriquez, D., & Goldstein, A. (2020). Covid-19’s Socio-Economic Impact on Low-Income Benefit Recipients: Early Evidence from Tracking Surveys [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/hpqd5

Schalkwyk, M. C. I. van, Hird, T. R., Maani, N., Petticrew, M., & Gilmore, A. B. (2020). The perils of preprints. BMJ, 370. https://doi.org/10.1136/bmj.m3111. https://t.co/qNPLYCeT99?amp=1

Ganong, P., Noel, P. J., & Vavra, J. S. (2020). US Unemployment Insurance Replacement Rates During the Pandemic (Working Paper No. 27216; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27216

McLaughlin, Patrick A, and Casey B Mulligan. ‘Three Myths about Federal Regulation’. Working Paper. Working Paper Series. National Bureau of Economic Research, May 2020. https://doi.org/10.3386/w27233.

When to Release the Lockdown? A Wellbeing Framework for Analysing Costs and Benefits. COVID-19 and the Labor Market. (n.d.). IZA – Institute of Labor Economics. Retrieved August 7, 2020, from https://covid-19.iza.org/publications/dp13186/

Hassan, T. A., Hollander, S., van Lent, L., & Tahoun, A. (2020). Firm-level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1 (Working Paper No. 26971; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w26971

Integrating Social Insurance and Social Assistance Programs for the Future World of Labor. COVID-19 and the Labor Market. (n.d.). IZA – Institute of Labor Economics. Retrieved August 5, 2020, from https://covid-19.iza.org/publications/dp13258/

If Sick-​Leave Becomes More Costly, Will I Go Back to Work? Could It Be Too Soon?. COVID-19 and the Labor Market. (n.d.). IZA – Institute of Labor Economics. Retrieved August 4, 2020, from https://covid-19.iza.org/publications/dp13379/

Optimal Unemployment Benefits in the Pandemic. COVID-19 and the Labor Market. (n.d.). IZA – Institute of Labor Economics. Retrieved August 1, 2020, from https://covid-19.iza.org/publications/dp13389/

Kaptchuk, G., Goldstein, D. G., Hargittai, E., Hofman, J., & Redmiles, E. M. (2020). How good is good enough for COVID19 apps? The influence of benefits, accuracy, and privacy on willingness to adopt. ArXiv:2005.04343 [Cs]. http://arxiv.org/abs/2005.04343

Briscese, G., Lacetera, N., Macis, M., & Tonin, M. (2020). Compliance with COVID-19 Social-Distancing Measures in Italy: The Role of Expectations and Duration (Working Paper No. 26916; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w26916

Xie, W., Campbell, S., & Zhang, W. (2020, May 5). Working Memory Capacity Predicts Individual Differences in Social Distancing Compliance during the COVID-19 Pandemic in the U.S. https://doi.org/10.31234/osf.io/3j69f

Morgan, L., Protopopova, A., Birkler, R. I. D., Itin-Shwartz, B., Sutton, G. A., gamliel, alexandra, Yakobson, B., & Raz, T. (2020). Human-dog relationships during COVID-19 pandemic; booming dog adoption during social isolation [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/s9k4y

Is Remote Work Here To Stay? (n.d.). NPR.Org. Retrieved July 4, 2020, from https://www.npr.org/sections/money/2020/06/30/882834590/is-remote-work-here-to-stay

Quintana, D. S., & Heathers, J. (2020). How podcasts can benefit science [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/ry5x9

Pandey, E. (2020, May 19). Companies weigh the potential of permanent work-from-home. Axios. Retrieved June 3, 2020, from https://www.axios.com/work-from-home-permanant-coronavirus-6680b1a5-6daa-40e5-a39f-665e8e73b477.html

Dougherty, C. (2020, May 31). Tenants Largely Stay Current on Rent, for Now. The New York Times. https://www.nytimes.com/2020/05/31/business/economy/coronavirus-rent-landlords-tenants.html

Mancini, A. D. (2020, May 28). Heterogeneous Mental Health Consequences of COVID-19: Costs and Benefits. https://doi.org/10.1037/tra0000894

Mehrotra, S., Rahimian, H., Barah, M., Luo, F., & Schantz, K. (2020 May 02). A model of supply-chain decisions for resource sharing with an application to ventilator allocation to combat COVID-19. Naval Research Logistics (NRL). https://doi.org/10.1002/nav.21905

Zoder-Martell, K., Markelz, A., Floress, M. T., Skriba, H. A., & Sayyah, L. E. N. (2020, May 6). Technology to Facilitate Telehealth in Applied Behavior Analysis. https://doi.org/10.31234/osf.io/nz5s7

Fradera, A. New study fails to find any psychological benefits of volunteering, but that doesn’t mean you should stop. (2017, March 14). Research Digest. https://digest.bps.org.uk/2017/03/14/new-study-fails-to-find-any-psychological-benefits-of-volunteering-but-that-doesnt-mean-you-should-stop/

Watzek, J., & Brosnan, S. (2020, April 30). Capuchin and rhesus monkeys show sunk cost effects in a psychomotor task. https://doi.org/10.31234/osf.io/qtgru

Hadavand, A., Hamermesh, D.S., & Wilson, W.W. (2020). Is scholarly refereeing productive (at the margin)? The National Bureau of Economic Research. https://www.nber.org/papers/w26614

Hamilton, J. L., Nesi, J., & Choukas-Bradley, S. (2020, April 29). Teens and social media during the COVID-19 pandemic: Staying socially connected while physically distant. Retrieved from psyarxiv.com/5stx4

Verbruggen, R. (2020 March 24). Another COVID Cost-Benefit Analysis. National Review. https://www.nationalreview.com/corner/another-covid-cost-benefit-analysis/

Breckon, J. (2020 April 16). Seven welcome Covid-19 trends. Researchprofessionalnews.com. https://www.researchprofessionalnews.com/rr-news-uk-views-of-the-uk-2020-4-seven-welcome-covid-19-trends/

Janiaud, P., Axfors, C., Saccilotto, R., & Hemkens, L. (2020). COVID-evidence: A living database of trials on interventions for COVID-19. https://doi.org/10.17605/OSF.IO/GEHFX

Thunstrom, L., Newbold, S., Finnoff, D., Ashworth, M., & Shogren, J. F. (2020). The Benefits and Costs of Using Social Distancing to Flatten the Curve for COVID-19 (SSRN Scholarly Paper ID 3561934). Social Science Research Network. https://doi.org/10.2139/ssrn.3561934

The potential benefits of blockchain

Estimated economic benefit of data linkage

the potential value from linking Census data to administrative data sets is only beginning to be realised and holds immense potential.(In other work for the Population Health Research Network, Lateral Economics concluded that data linkage generated over $16 for every dollar invested).

Economic benefit of the Census.

Our estimates suggest the benefits of running the Census easily outweigh its costs in the order of$6 of economic value for each $1 it costs. On this reckoning, the cost of the Census would have to rise to six times its current cost –to around $3 billion every five years –before it startedto become cost ineffective

A GAAR reassessment upheld, primarily on the basis that the Tax Court judge was correct to look at one of the steps in the series of transactions on an objective basis and ask if the permissible objective of creditor protection could have been achieved without it, without which it was open to him to find that its primary purpose was to achieve the tax benefit.

Existence of a bona fide non-tax purpose for a series of transactions does not exclude possibility that the primary purpose of one of the transactions in the series is to obtain a tax benefit.

Clinical trials will most certainly first include those patients with the highest risk of relapse. However, long term, everything will depend on the risk/ benefit trade off: if an effective, simple, well-tolerated and cost-effective treatment was available (let's imagine a single short low-dose PD1 for any early Melanoma patient) that prevented progression for most patients would be very different from a highly toxic, expensive treatment that doesn't work for everyone (think Ipi 10mg/kg adjuvant)- so everything is in the trade-off

this seems to be the minimum - how can you take this further? What about community benefit agreements?

source: https://s3.amazonaws.com/prod_foundationapp/364221/lessons/35/1384378776-john-carlton-1.pdf

from: https://campus.thefoundation.com/courses/1/lessons/35